克隆性血液形成对放射治疗后固体瘤进展的影响
Jacqueline J Tao1, Jeremy Setton2, Pablo Sánchez Vela3
1Columbia University Medical Center, New York, NY.
JCO precision oncology
|April 18, 2025
概括
克隆性血液形成 (CH) 不会影响固体瘤的放射治疗反应. 这项研究没有发现CH和无CH患者之间瘤进展的差异,这表明CH不会影响RT结果.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 癌症研究 癌症研究
背景情况:
- 克隆性血液形成 (CH) 与非血液性癌症的不良结果有关.
- 在固体瘤中,CH对放射治疗 (RT) 反应的影响在很大程度上是未知的.
研究的目的:
- 为了研究结核造血 (CH) 与有固体瘤的患者对放射治疗 (RT) 的反应之间的关联.
- 为了确定CH的存在是否会影响照射瘤的进展.
主要方法:
- 分析了412名患有固体瘤的患者,他们接受了RT,并接受了潜在的瘤和匹配的WBC测序.
- 使用经过验证的管道检测CH变体,并比较有和没有CH的患者的照射瘤进展.
- 包括患有非致病性体质或生殖系ATM或FAT1突变的患者.
主要成果:
- 412名患者中有161名 (39.1%) 呈现CH,其中DNMT3A,PPM1D,TET2和TP53是最常发生突变的基因.
- 细灰竞争风险分析显示,CH和无CH患者之间照射瘤进展没有显著差异 (HR,1.09;P = .68).
- 对CH变异基因频率和癌症驱动突变的次分析没有显示与RT反应的关联.
结论:
- 克隆性血液形成 (CH) 似乎不会影响有固体瘤的患者的放射性瘤进展.
- 需要进一步的研究才能充分理解CH对固体瘤治疗响应性的临床影响.
相关概念视频
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K


